アジア太平洋の合成ホルモン市場：製品タイプ別、投与経路別、用途別、エンドユーザー別、国別 - 分析と予測（2023年～2033年）

アジア太平洋の合成ホルモンの市場規模は、2023年に24億1,000万米ドルとなりました。

同市場は、2023年～2033年の予測期間中に7.34%のCAGRで拡大し、2033年には48億9,000万米ドルに達すると予測されています。市場の成長を牽引しているのは、アジア太平洋の合成ホルモン分野における画期的な進歩の可能性であり、数多くの主要企業が革新的な合成ホルモンの開発に積極的に取り組んでいます。

アジア太平洋の合成ホルモン市場は、医療技術の進歩と効果的なホルモン療法に対する需要の高まりにより、大幅な成長が見込まれています。多くの内分泌疾患、生殖障害、慢性疾患の治療に使用される合成ホルモンは、その有効性と精度の高さから人気が高まっています。中国、インド、日本などの国々は、強力な医療インフラ、有能な専門家、支援する規制枠組みを活用し、市場拡大をリードしています。

アジア太平洋の主要企業は、満たされていない医療要件を満たし、患者の転帰を改善する新規合成ホルモンを製造するため、研究開発に大規模な投資を行っています。同産業はまた、高齢化、ヘルスケア知識の増加、ホルモン関連疾患の増加からも恩恵を受けています。

当レポートでは、アジア太平洋の合成ホルモン市場について調査し、市場の概要とともに、製品タイプ別、投与経路別、用途別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 動向：現在および将来の影響評価
• 市場規模と成長の可能性、10億米ドル、2022年～2033年
• 研究開発レビュー
• 市場力学：概要
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第2章 地域

• 地域別概要
• 促進要因と抑制要因
• アジア太平洋
  • 地域概要
  • 日本
  • 中国
  • オーストラリア
  • 韓国
  • インド
  • その他のアジア太平洋地域

第3章 市場-競合ベンチマーキングと企業プロファイル

• 企業評価
  • Changchun GeneScience Pharmaceutical Co., Ltd.

第4章 調査手法

List of Figures

• Figure 1: Asia-Pacific Synthetic Hormones Optimistic, Pessimistic and Realistic Growth, 2023, 2027,2033
• Figure 2: Asia-Pacific Synthetic Hormones Market (by Product Type), $Billion, 2022, 2027, and 2033
• Figure 3: Asia-Pacific Synthetic Hormones Market (by Route of Administration), $Billion, 2022, 2027, and 2033
• Figure 4: Key Events to Keep Track of within Synthetic Hormones Market
• Figure 5: Benefits of Personalized Synthetic Hormone Therapies
• Figure 6: AI Utilization in Synthetic Hormones
• Figure 7: Asia-Pacific Synthetic Hormones Market, $Billion, 2022-2033
• Figure 8: Patent Published (by Country), January 2020-December 2023
• Figure 9: Patent Published (by Year), January 2020-December 2023
• Figure 10: Impact Analysis of Market Dynamics, 2022-2033
• Figure 11: Trends in Occurrence of Diabetes, 2001-2020
• Figure 12: Hormonal Disorders and their Prevalence Globally, 2020
• Figure 13: Uptake of HRT Medicines and Prescribing Rate, Europe
• Figure 14: Examples of a Few Technological Advancements
• Figure 15: Factors Contributing to High Developmental Costs
• Figure 16: Cost of Synthetic Hormone Therapy
• Figure 17: Regulatory Process for Synthetic Hormones
• Figure 18: Indications and Applications of Synthetic Hormones
• Figure 19: Factors Contributing to Precision Medicine for Synthetic Hormones
• Figure 20: Strategic Initiatives, 2021-2023
• Figure 21: Data Triangulation
• Figure 22: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Synthetic Hormones Market (by Region), $Billion, 2022-2033
• Table 4: Asia-Pacific Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 5: Asia-Pacific Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 6: Asia-Pacific Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 7: Asia-Pacific Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 8: Japan Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 9: Japan Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 10: Japan Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 11: Japan Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 12: China Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 13: China Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 14: China Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 15: China Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 16: Australia Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 17: Australia Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 18: Australia Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 19: Australia Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 20: South Korea Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 21: South Korea Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 22: South Korea Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 23: South Korea Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 24: India Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 25: India Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 26: India Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 27: India Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 28: Rest-of-Asia-Pacific Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
• Table 29: Rest-of-Asia-Pacific Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
• Table 30: Rest-of-Asia-Pacific Synthetic Hormones Market (by Application), $Billion, 2022-2033
• Table 31: Rest-of-Asia-Pacific Synthetic Hormones Market (by End User), $Billion, 2022-2033
• Table 32: Market Share

Introduction to Asia-Pacific (APAC) Synthetic Hormones Market

The Asia-Pacific synthetic hormones market size was estimated at $2.41 billion in 2023 and is expected to reach $4.89 billion by 2033, growing at a CAGR of 7.34% during the forecast period 2023-2033. The market's growth is driven by the potential for groundbreaking advancements in the APAC synthetic hormones sector, with numerous key players actively working on developing innovative synthetic hormones.

Market Introduction

The Asia-Pacific (APAC) Synthetic Hormones Market is expected to grow significantly, driven by advances in medical technology and rising demand for effective hormonal therapy. Synthetic hormones, which are used to treat a number of endocrine problems, reproductive health difficulties, and chronic ailments, are increasing popularity due to their effectiveness and precision. Countries such as China, India, and Japan are leading the market expansion, leveraging strong healthcare infrastructures, qualified experts, and supporting regulatory frameworks.

Key players in the APAC area are investing extensively in R&D to produce novel synthetic hormones that will meet unmet medical requirements and improve patient outcomes. The industry is also benefiting from an older population, more healthcare knowledge, and rising rates of hormone-related illnesses. This report provides an in-depth analysis of the current market dynamics, major stakeholders, regulatory landscape, and future trends influencing the APAC Synthetic Hormones Market, providing useful information for investors and industry participants looking to capitalize on new opportunities.

Market Segmentation:

Segmentation 1: by Product Type

• Steroid Hormones
• Peptide Hormones
• Others

Segmentation 2: by Route of Administration

• Subcutaneous
• Oral
• Intravenous/Intramuscular
• Others

Segmentation 3: by Application

• Diabetes
• Growth Hormone Deficiency
• Contraception
• Male Hypogonadism
• Menopause
• Others

Segmentation 4: by End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Segmentation 5: by Region

• Japan
• China
• Australia
• South Korea
• India
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific synthetic hormones market (by product type) has been segmented based on product type, including peptide hormones, steroid hormones, and others. Moreover, the study provides the reader with a detailed understanding of the different routes of administration and application.

Growth/Marketing Strategy: To foster growth in the synthetic hormones market, a dual strategy focusing on research and development for safer, more effective formulations, alongside expanding global outreach through strategic partnerships and education campaigns, is essential. Emphasizing personalized medicine and leveraging digital platforms for market expansion and patient engagement can also be pivotal in driving market growth and visibility.

Competitive Strategy: Key players in the Asia-Pacific synthetic hormones market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific synthetic hormones market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Trend 1: Personalized Synthetic Hormones Therapies
  • 1.1.2 Trend 2: Integration of Artificial Intelligence (AI)
• 1.2 Market Footprint and Growth Potential, $Billion, 2022-2033
• 1.3 Research and Development Review
  • 1.3.1 Patent Publishing Trend (by Country)
  • 1.3.2 Patent Publishing Trend (by Year)
• 1.4 Market Dynamics: Overview
  • 1.4.1 Market Drivers
  • 1.4.2 Market Restraints
  • 1.4.3 Market Opportunities

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Asia-Pacific
  • 2.3.1 Regional Overview
    • 2.3.1.1 Driving Factors for Market Growth
    • 2.3.1.2 Factors Challenging the Market
  • 2.3.2 Japan
  • 2.3.3 China
  • 2.3.4 Australia
  • 2.3.5 South Korea
  • 2.3.6 India
  • 2.3.7 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Company Assessment
  • 3.1.1 Changchun GeneScience Pharmaceutical Co., Ltd.
    • 3.1.1.1 Overview
    • 3.1.1.2 Top Products
    • 3.1.1.3 Top Competitors
    • 3.1.1.4 Key Personnel
    • 3.1.1.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation